Command Palette

Search for a command to run...

BIOCON

389.8-5.05 (-1.28%)

Quarterly ResultsProfit & LossBalance SheetCash Flow

Key Insights

POSITIVE
  • Significant rise in net sales to ₹4417 crore in Q1 202503, up from ₹3821.4 crore last quarter.
  • Operating margin improved substantially to 9.72% this quarter, reflecting enhanced operational efficiency.
  • Net profit surged to ₹459.4 crore, showcasing a strong recovery compared to previous quarters.
NEGATIVE
  • Company experienced a cash flow shortfall with a 10% decrease this year [Dummy Data]
  • Company’s strategic partnerships have yet to generate expected growth. [Dummy Data]
  • Company’s EBITDA shrank at a CAGR of -8% over the past 3 years. [Dummy Data]
Quarterly Results Data
FieldTrendMar 24Jun 24Sep 24Dec 24Mar 25Jun 25Sep 25Dec 25
Revenue
3,917.103,432.903,590.403,821.404,4173,941.904,295.504,173
Expenses
3,635.203,453.903,550.503,718.403,987.503,924.704,205.304,064.70
Operating Profit
281.90-2139.90103429.5017.2090.20108.30
Other Income
48.601,134.5032.5034.8036.9079.7093117.30
Interest
227236225.60223.40212.40276.70272.20209.90
Depreciation
407405.40419.90425.40436.30455473515.30
Profit Before Tax
3191,145.5098.40155.90486.8096.90171.30-67.80
Tax
96.10283.7071.3074.8027.407.7038.50-16
Net Profit
222.90861.8027.1081.10459.4089.20132.80-51.80
EPS in Rs
1.135.51-0.130.212.880.260.661.08